Tech Company Financing Transactions
Sympatient Funding Round
Sympatient, based in Hamburg, secured $7.4 million from Verve Ventures and private investors.
Transaction Overview
Company Name
Announced On
10/7/2022
Transaction Type
Venture Equity
Amount
$7,400,000
Round
Series A
Investors
Verve Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Koppel 34-36
Hamburg, 20099
Germany
Hamburg, 20099
Germany
Phone
Website
Email Address
Overview
Our story began in 2016, when our co-founder Julian Angern started researching VR-based anxiety therapy at the University Medical Center Schleswig-Holstein. Ever since we have been developing our treatments according to the highest standards in quality and efficacy. Our care offerings provide patients with the flexibility they need, while incorporating contacts to real therapists and doctors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Technical Officer
Chris Hinz
Chief Technical Officer
Jan-Niklas Rösch
Co-Founder
Christian Angern
Co-Founder
Julian Angern
Co-Founder
Benedikt Reinke
VP - R & D
Richard Wermes
Browse more venture capital transactions:
Prev: 10/7/2022: Gamurs venture capital transaction
Next: 10/7/2022: Lizy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs